GLP-1s May Increase Post-Endoscopy Aspiration Pneumonia Risk GLP-1s May Increase Post-Endoscopy Aspiration Pneumonia Risk
Although the overall incidence remains low, patients on GLP-1s have a 33% higher chance of aspiration pneumonia after endoscopic procedures, according to a new large population-based study.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 18, 2024 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
Warning over 'chemical cosh' doled out to dementia sufferers as experts warn dangerous drugs are even more harmful than feared
Academics from the Universities of Manchester, Nottingham, Edinburgh and Dundee found that dementia patients had a two-fold increased risk of developing pneumonia. (Source: the Mail online | Health)
Source: the Mail online | Health - April 17, 2024 Category: Consumer Health News Source Type: news
Aspiration Pneumonia Risk Increased for GLP-1 RA Users Undergoing Endoscopy
FRIDAY, April 12, 2024 -- Patients using glucagon-like peptide 1 receptor agonists (GLP-1 RAs) undergoing endoscopic procedures have an increased risk for aspiration pneumonia, according to a study published online March 27 in Gastroenterology.
Yee... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 12, 2024 Category: Pharmaceuticals Source Type: news
SimonMed to integrate Infervision tech into its facilities
SimonMed Imaging is integrating Infervision’s AI-powered InferRead Lung CT.AI technology into its facilities.
The move aims to improve the identification of pulmonary nodules and to provide 3D characterization and comparison of nodules. It will be integrated into CT chest scan readings, including those for lung cancer screening.
The technology automatically displays boxes around nodules in a new series providing standardized reporting of all nodule characteristics including image number, type of nodule, and volume. It also assesses previous exams to track changes in diameter and volume. In cases where pneumonia is su...
Source: AuntMinnie.com Headlines - April 11, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
Preoperative GLP-1 Agonist Use Does Not Increase Aspiration
TUESDAY, April 9, 2024 -- Preoperative glucagon-like peptide-1 (GLP-1) agonist use does not increase the risk for aspiration or subsequent pneumonia in patients undergoing various surgical procedures, according to a study presented at the 49th... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 9, 2024 Category: Pharmaceuticals Source Type: news
Seniors, Stay Away From Young Kids to Avoid Pneumonia: Study
THURSDAY, March 4, 2024 -- Sticky fingers, runny noses: Little kids are sweet, but they can also pass on dangerous germs to loving grandparents, new research confirms.
The study found that contact with pre-school and kindergarten-aged kids may be... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 4, 2024 Category: General Medicine Source Type: news
FDA Approves Zevtera (ceftobiprole medocaril sodium) for Bacteremia, Skin and Skin Structure Infections, and Pneumonia
Allschwil, Switzerland, April 04, 2024 -- Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 4, 2024 Category: Drugs & Pharmacology Source Type: news
FDA Approves New Antibiotic for Three Different Uses
The FDA approved a new antibiotic for the treatment of certain patients with Staphylococcus aureus bloodstream infections, including those with right-sided infective endocarditis; acute bacterial skin and skin structure infections; and community-acquired bacterial pneumonia. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 3, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
GLP-1 Users May Have Increased Endoscopy-Related Aspiration Pneumonia Risk
(MedPage Today) -- People on GLP-1 receptor agonists (RAs) had a significantly higher risk of aspiration pneumonia after undergoing gastrointestinal endoscopy, researchers reported.
Compared with 0.63% of non-users, 0.83% patients on a GLP-1 receptor... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - April 1, 2024 Category: Surgery Source Type: news
Inappropriate Diagnosis of Pneumonia Common in Hospitalized Adults
WEDNESDAY, March 27, 2024 -- Inappropriate diagnosis of community-acquired pneumonia (CAP) in hospitalized adults is common, especially among older adults and those with dementia, according to a study published online March 25 in JAMA Internal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 27, 2024 Category: Pharmaceuticals Source Type: news
Doctors warn of a NEW fatal complication from Ozempic and Wegovy that may cause food to be sucked into lungs and choke patients to death
Researchers at Cedars-Sinai Medical Center in Los Angeles found that patients taking GLP-1 agonists before an endoscopy had a 33 percent greater risk of aspiration pneumonia. (Source: the Mail online | Health)
Source: the Mail online | Health - March 27, 2024 Category: Consumer Health News Source Type: news
Inappropriate Dx of Pneumonia Common in Hospitalized Adults
(MedPage Today) -- About one in eight diagnoses of community-acquired pneumonia (CAP) in hospitalized adults are inappropriate, a prospective cohort study involving Michigan hospitals found.
In total, 12% of the more than 17,000 patients treated... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - March 25, 2024 Category: Infectious Diseases Source Type: news
Pneumonia treatment in kitchen 'tremendous'
Sean Daly says it is a bonus knowing he helped free up a bed at Daisy Hill Hospital for someone else. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - March 19, 2024 Category: Consumer Health News Source Type: news
The Most Exciting New Advances in Managing COPD
The Global Initiative for Chronic Obstructive Lung Disease, or GOLD, is the world’s preeminent COPD research and advocacy organization. Founded in 1997 in collaboration with the U.S. National Institutes of Health and the World Health Organization, one of GOLD’s stated aims is to “improve prevention and treatment of this lung disease.”
In its 2023 global strategy report, GOLD changed its definition of COPD—which many in the profession viewed as overdue. Specifically, the new definition emphasized the heterogeneity of COPD in terms of its underlying drivers and long-term disease course.
[ti...
Source: TIME: Health - March 18, 2024 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized freelance Source Type: news
European Commission approves Pfizer & #039;s PREVENAR 20 ® to help protect infants and children against pneumococcal disease
Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization for the company's 20-valent pneumococcal conjugate vaccine, marketed in the European Union under the brand name PREVENAR 20®, for active immunization for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age. (Source: World Pharma News)
Source: World Pharma News - March 13, 2024 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news
